期刊文献+

卵巢交界性肿瘤的临床特点及预后影响因素分析 被引量:6

The analysis of clinical features and prognostic factors of borderline ovarian tumors
下载PDF
导出
摘要 目的观察不同病理类型卵巢交界性肿瘤的临床特点,分析影响预后的相关因素。方法回顾性分析该科治疗的60例卵巢交界性肿瘤患者的临床资料,根据病理分型分为浆液组和黏液组,比较两组患者的临床特点,探讨影响预后的临床因素。结果 60例卵巢交界性肿瘤以浆液性(n=22,36.7%)和黏液性(n=34,56.6%)为主,共占93.3%。浆液组和黏液组肿瘤大小、双侧卵巢累及率、肿瘤具多房性、呈乳头状、癌抗原(CA)125与CA19-9比较差异有统计学意义(P<0.05)。56例患者均获得随访,5年总生存率和无瘤生存率分别为96.8%和94.2%。对5年无瘤生存率进行单因素分析,结果提示年龄、肿瘤大小、病理类型、是否绝经、手术方式、术后化疗、CA125、CA19-9等因素与患者预后无关;而国际妇产科联盟(FIGO)分期、微浸润、腹膜种植与预后有关(P<0.05)。多因素Logistic回归分析显示,FIGO分期低的患者预后更好(OR=0.348,P<0.05),而微浸润(OR=8.458,P<0.05)、腹膜种植(OR=7.109,P<0.05)是影响预后的危险因素。结论卵巢交界性肿瘤发病年龄轻,预后良好,且浆液性与黏液性卵巢交界性肿瘤具有一定的不同点。肿瘤FIGO分期、微浸润、腹膜种植可影响预后,对存在这些高危因素的患者应长期随访。 Objective To observe the clinical features of different pathological borderline ovarian tumors and evaluate its prog-nostic factors .Methods The clinical data of 60 patients were retrospectively analyzed .Based on different histological types ,these patients were divided into serous borderline ovarian tumors group and mucins borderline ovarian tumors group .The clinical features was compared .Results 60 cases of epithelial borderline ovarian tumors contained 22(36 .7% ) serous borderline ovarian tumors and 34(56 .6% ) mucins borderline ovarian tumors .The tumor size ,ratio of bi-laterality ,multi-locular cyst ,papillary patterns ,level of CA-125 or CA19-9 had significant differences between the two groups(P&lt;0 .05) .56 patients were followed up ,the 5-year overall survival and disease-free survival were 96 .8% and 94 .2% ,respectively .Univariate analysis of 5 years disease-free survival showed that ,age ,tumor size ,histological types ,menopause ,operation types ,chemotherapy and level of CA-125 or CA19-9 were irrelevant to prognosis of patients ,and FIGO stage ,micro-invasion ,peritoneal implants were relevant factors to prognosis .Multivariate analyses showed that ,the patients with low stage of FIGO (OR=0 .348 ,P&lt;0 .05) had better prognosis ,while the patients with micro-inva-sion(OR= 8 .458 ,P&lt; 0 .05) ,peritoneal implants (OR= 7 .109 ,P&lt; 0 .05) had worse prognosis .Conclusion Borderline ovarian tumors frequently affected younger patients and has an excellent prognosis .there were some different clinical characteristics be-tween serous borderline ovarian tumors and mucins borderline ovarian tumors .All patients with borderline ovarian tumors should follow-up ,especially these who had high risks as micro-invasion ,peritoneal implants and high FIGO stage .
作者 梁茹英
出处 《重庆医学》 CAS CSCD 北大核心 2014年第8期927-929,共3页 Chongqing medicine
关键词 卵巢肿瘤 回顾性研究 因素分析 统计学 预后 ovarian neoplasm retrospective studies factor analysis,statistical prognosis
  • 相关文献

参考文献13

  • 1梁旭东,曾浩霞,李艺,祝洪澜,沈丹华,廖晓云,崔恒,魏丽惠.卵巢交界性上皮性肿瘤临床分析[J].中国妇产科临床杂志,2010,11(6):406-409. 被引量:14
  • 2Brun JL, Cortez A, Rouzier R, et al. Factors influencing the use and accuracy of frozen section diagnosis of epithe-lial ovarian tumors[J]. Am J Obstet Gynecol , 2008, 199 (3),244.
  • 3王雯智,刘晓霞,岳瑛.卵巢交界性肿瘤的诊治进展[J].中国妇幼保健,2011,26(11):1747-1748. 被引量:6
  • 4Park JY, Kim DY, Kim JH, et al. Surgical management of borderline ovarian tumors, The role of fertility-sparing surgery. [J]. Gynecol Oncol , 2009,1130) ,75-82.
  • 5Kokawa K, Mikami Y, Sakata H, et al. Clinical outcome and prognostic factors in borderline tumors of the ovary. Results from 17 years' experience in the Kinki District of Japan (1990-2006) [J]. Eur J Gynaecol Oncol , 2009, 30 (2),155-161.
  • 6Poncelet C, Fauvet R, Yazbeck C, et al. Impact of serum tumor marker determination on the management of women with borderline ovarian tumors, multivariate analysis of a French multicentre study[J]. Eur J Surg Oncol , 2010,36(11),1066-1072.
  • 7Kelly PJ ,Archbold Pv Price JH,et al. Serum CA19. 9 levels are commonly elevated in primary ovarian mucinous tumours but cannot be used to predict the histological subtype[J]. J Clin Pathol , 2010,63 (2) ,169-173.
  • 8Vrabie CD, Petrescu A, Waller M, et al. Clinical factors and biomarkers in ovarian tumors development[J]. Rom J Morphol Embryol,2008,49(3) ,327-338.
  • 9Zanetta G, Rota S, Chiari S, et al. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma, a prospective study [J]. J Clin Oncol , 2001, 19(0) ,2658-2664.
  • 10Koutlaki Nv Dimitraki Mv Zervoudis Sv et al. Conservative surgery for borderline ovarian tumors-emphasis on fertility preservation. A review [J]. Chirurgia (Bucur ) , 2011, 106(6) ,715-722.

二级参考文献51

  • 1冷金花,郎景和.卵巢交界性肿瘤的治疗[J].中华妇产科杂志,1993,28(8):498-501. 被引量:6
  • 2顾美皎.卵巢交界性肿瘤的诊治[J].实用肿瘤杂志,2006,21(6):496-497. 被引量:7
  • 3Vandenput I, Amant F, Vergote I. Peritoneal recurrences might be less common in advanced stage serous borderline ovarian tumors that were treated by laparotomy [ J ]. Gynecol Oncol, 2005, 98 ( 3 ): 523-525.
  • 4Fortin A, Mofice P, Thoury A, et al. Impact of infertility drugs after treatment of borderline ovarian tumors:Resuhs of a retrospective muhicenter study [J ]. Fertil Steril, 2007, 87 (3): 591-596.
  • 5Park CW, Yang KM, Kim HO, et al. Outcomes of controlled ovarian hyperstimulation/in vitro fertilization for infertile patients with borderline ovarian tumor after conservative treatment [J]. J Korean Med Sci, 2007, 22 (Suppl): 134-138.
  • 6Olszewska H, Stukan M, Emerich J. Clinical analysis of patients with recurrences of borderline ovarian tumors including surgical treatment [J]. Ginekol Pol, 2005, 76( 10): 782-787.
  • 7Yokoyama Y, Moriya T, Takano T, et al. Clinical outcome and risk factors for recurrence in borderline ovarian turnouts [J ]. Br J Cancer, 2006, 94( 11 ): 1586-1591.
  • 8Vrabie CD, Petrescu A, Waller M, et al. Clinical factors and biomarkers in ovarian tumors development[J]. Rom J Morphol Embryol, 2008, 49(3 ): 327-338.
  • 9Ayhan A, Guven S, Guven ES, et al. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors? [J]. Acta Obstet Gynecol Scand, 2007, 86 (4): 484-490.
  • 10Van Calster B, Timmerman D, Bourne T, et al. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125 [J]. J Natl Cancer Inst, 2007, 99(22): 1706-1714.

共引文献19

同被引文献59

  • 1段微,范逢晓.保留生育功能手术对卵巢交界性肿瘤临床治疗效果的影响[J].中国实用妇科与产科杂志,2006,22(6):449-450. 被引量:11
  • 2邵汇琳,沈丹华,薛卫成,李艺,虞有智.卵巢上皮性肿瘤的临床病理特征及其细胞周期素D1和p53蛋白表达的研究[J].中华妇产科杂志,2007,42(4):227-232. 被引量:10
  • 3唐军,赖娟,耿京,吕君.术前诊断卵巢交界性肿瘤的超声特征[J].中国妇产科临床杂志,2007,8(3):172-174. 被引量:18
  • 4Sorsukolrat S,Tuipae S. Prognostic factors and survival of borderline ovarian tumors in rajavithi hospital between 1979-2006 AD[J]. J Med Assoc Thai,2012,95(9): 1141-1148.
  • 5Messalli EM,Grauso F. Borderline ovarian tumors:features and controversial aspects[J]. Eur J Obestet Gynecol Reprod Biol,2013,167(1):86-89.
  • 6Kanat-Pektas M, Ozat M, Gungor T, et al. Fertility outcomeafter conservati,Je surgery for borderline ovarian tumors :a single center experience[J]. Arch Gyneeol Obestet, 2011, 284 : 1253-1258.
  • 7De Laco P,Ferrero A,Rosati F,et al. Behaviour of ovarian tumors of low malignant potential treated with conservative surgery[J]. Eur J Surg Oncol, 2009,35 : 643-648.
  • 8Kanat-Pektas M, Ozat M, Gungor T,et al. Complete lymph node dissection :is it essential for treatment of borderline epithelial ovarian tumors? [J]. Arch Gynecol Obestet, 2011,283 : 879-884.
  • 9Menczer J,Chetrit A,Sadetzki S,et al. The effect of hys- terectomy on survival of patients with borderline ovarian tumors[J]. Gynecol Oncol, 2012,125(2) : 372-375.
  • 10Sevcik L,Klat L,Koliba P,et al. Radical surgical therapy and role of adjuvant chemotherapy in ovarian tumors of borderline malignancy[J]. Cerka Gynekol,2004,69(6): 488-492.

引证文献6

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部